Fundacio Assistencial De Mutua De Terrassa Fpc — Clinical Trial Site

65 Registered trials

25 Currently recruiting

Organisation

Fundacio Assistencial De Mutua De Terrassa Fpc

Location

Terrassa, Spain

Identifier

ORG-100044208

Address

Calle De San Antonio No 32, 08221, Spain

Departments

#354: Neurology
#3802:UCI/medicina intensiva
#40453; Unitat de Recerca de Neurologia
#40453: Neurologia
#40453: Unitat de Recerca de Neurologia
3001; Enfermedades Infecciosas
7003:Oncologia
9406:Oncologia
Cardiology department
Clinical Haematology
Gastroenterology
Haematology
Hematología
Hematology
Intensive Care Medicine
Intensive Care Unit
Medica Oncology
Medical Doctor
Medical Oncology
Medicina Interna
N/A
NA
Neurologia
Neurology
Neurology Department
Obstetrician and Gynecologist
Oncology
Oncology Department
Orthopedic Surgery and Traumatology Service (Knee Unit)
PADES
Servicio de digestivo
Servicio de Neurología

Clinical trials at this site (65)

Search interface

An outpatient study to learn if Staccato Alprazolam is safe and effective when treating long seizures in children ≥12 years of age and adult… Recruiting

2024-510950-29-00 Stereotypical prolonged seizure 5 2022-07-21
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Resectable, Early-stage (II to IIIB) Non-small Cell Lun 4 2022-06-10
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31
Preemptive treatment with venetoclax plus azacitidine in patients diagnosed with acute myeloid leukemia (AML) with persistence or reappearan… Ended

2024-510648-29-00 Patients diagnosed with acute myeloid leukemia (AML) wi 10 2024-12-12
A study to learn about the safety of long-term treatment with brivaracetam in children and young adults with childhood or juvenile absence e… Ended

2023-508095-11-00 Childhood Absence Epilepsy 5 2024-11-27
A Randomized Phase 2 Study of Ocular Toxicity Evaluation and Mitigation During Treatment with Mirvetuximab Soravtansine in Patients with Rec… Ended

2023-505617-24-00 Recurrent Ovarian Cancer with High Folate Receptor-Alph 4 2024-11-05
Multicentric phase II trial to evaluate the efficacy and safety of Ibrutinib in combination with rituximab in patients with indolent clinica… Ended

2024-512370-94-00 Mantle Cell Lymphoma 4 2024-06-13
A Phase 1 first-in-human study evaluating safety, pharmacokinetics and efficacy of ABBV-706 as monotherapy and in combination with budigalim… Ended

2023-504598-18-00 Advanced solid tumors 1 2024-04-03
Study to evaluate the efficacy and safety of BGB-11417 in participants with Waldenström’s Macroglobulinemia Ended

2023-503235-18-00 previously untreated WM 4 2024-01-31
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
A study to test trimodulin in adult hospitalized patients with severe pneumonia Ended

2022-501352-28-00 Severe community-acquired pneumonia (sCAP) 5 2023-06-07
Study of chemotherapy and immunotherapy before and after surgery in patients with non-small cell lung cancer whose tumor is located in the u… Ended

2024-512359-19-00 Resectable Non-small cell lung cancer Pancoast tumor 4 2023-05-12
A Clinical Study to evaluate the long-term safety of Daratumumab in combination with standard bone marrow cancer treatment regiments Ended

2022-500138-27-01 Multiple Myeloma 5 2023-02-28
A Phase 3 Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant Ended

2023-508897-27-00 Multiple Myeloma 5 2022-04-28
A Phase 3 study of Tafasitamab plus Lenalidomide in addition to Rituximab, versus Lenalidomide plus Rituximab in patients With Relapsed/Refr… Ended

2023-504684-16-00 follicular lymphoma (FL) and marginal zone lymphoma (MZ 5 2021-06-05
Clinical trial comparing Trastuzumab Deruxtecan with Trastuzumab Emtansine in high-risk HER2-positive patients with residual breast cancer f… Ended

2023-507961-24-00 High-Risk HER2-Positive Breast Cancer 5 2021-04-19
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Study to compare the efficacy and safety of NT 201 (botulinum toxin) with placebo for the treatment of lower limb spasticity caused by strok… Ended

2023-505810-12-00 Lower limb spasticity 5 2019-09-03
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404… Halted

2023-505096-68-00 Preclinical Alzheimer’s Disease 4 2025-01-14
Phase 2 Study of CAL02 plus Standard of Care in Severe Community-Acquired Bacterial Pneumonia (SCABP) Halted

2022-502049-91-00 SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP) 4 2023-09-26
GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease. Ended

2025-521107-42-00 Alzheimer's Disease 4 2025-11-25
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1) Ended

2024-514559-13-00 Focal Epilepsy 10 2024-11-26